Phosphocreatine attenuates doxorubicin-induced cardiotoxicity by inhibiting oxidative stress and activating TAK1 to promote myocardial survival in vivo and in vitro

Mitochondrial Sirtuins and Doxorubicin-induced Cardiotoxicity

(2021) Ling He et al.   Cardiovascular Toxicology

Effects of doxorubicin‐induced cardiotoxicity on cardiac mitochondrial dynamics and mitochondrial function: Insights for future interventions

(2020) Nichanan Osataphan et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

Interleukin-22 deficiency alleviates doxorubicin-induced oxidative stress and cardiac injury via the p38 MAPK/macrophage/Fizz3 axis in mice

(2020) Jing Ye et al.   Redox Biology

Phosphocreatine Attenuates Isoproterenol-Induced Cardiac Fibrosis and Cardiomyocyte Apoptosis

(2019) Hui Dai et al.   Biomed Research International

Ferroptosis as a target for protection against cardiomyopathy

(2019) Xuexian Fang et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

FNDC5 alleviates oxidative stress and cardiomyocyte apoptosis in doxorubicin-induced cardiotoxicity via activating AKT

(2019) Xin Zhang et al.   CELL DEATH AND DIFFERENTIATION

Oxidative stress injury in doxorubicin-induced cardiotoxicity

(2019) Mei Songbo et al.   TOXICOLOGY LETTERS

Doxorubicin induces cardiomyocyte pyroptosis via the TINCR-mediated posttranscriptional stabilization of NLR family pyrin domain containing 3

(2019) Liping Meng et al.   JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY

Phosphocreatine Improves Cardiac Dysfunction by Normalizing Mitochondrial Respiratory Function through JAK2/STAT3 Signaling Pathway In Vivo and In Vitro

(2019) Eskandar Qaed et al.   Oxidative Medicine and Cellular Longevity

Integration of cardiac energetics, function and histology from isolated rat hearts perfused with doxorubicin and doxorubicin-ol; a model for use in drug safety evaluations

(2018) Kim A. Henderson et al.   JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS

Creatine Phosphate Administration in Cell Energy Impairment Conditions: A Summary of Past and Present Research

(2017) A.V. Gaddi et al.   Heart Lung and Circulation

Creatine phosphate disodium salt protects against Dox-induced cardiotoxicity by increasing calumenin

(2017) Yu Wang et al.   Medical Molecular Morphology

TAK1 inhibitor 5Z-7-oxozeaenol sensitizes cervical cancer to doxorubicin-induced apoptosis

(2017) Shan Guan et al.   Oncotarget

CaMKII is a RIP3 substrate mediating ischemia- and oxidative stress–induced myocardial necroptosis

(2016) Ting Zhang et al.   NATURE MEDICINE

TAK1 inhibitor NG25 enhances doxorubicin-mediated apoptosis in breast cancer cells

(2016) Zhenyu Wang et al.   Scientific Reports

Anthracyclines/trastuzumab: new aspects of cardiotoxicity and molecular mechanisms

(2015) Luc Rochette et al.   TRENDS IN PHARMACOLOGICAL SCIENCES

TAK1 Regulates Myocardial Response to Pathological Stress via NFAT, NFκB and Bnip3 Pathways

(2015) Lei Li et al.   Scientific Reports

Transforming Growth Factor β–Activated Kinase 1 Signaling Pathway Critically Regulates Myocardial Survival and Remodeling

(2014) Lei Li et al.   CIRCULATION

TAK1 inhibitor 5Z-7-oxozeaenol sensitizes neuroblastoma to chemotherapy

(2013) Yihui Fan et al.   APOPTOSIS

Doxorubicin-Induced Cardiotoxicity: From Bioenergetic Failure and Cell Death to Cardiomyopathy

(2013) Filipa S. Carvalho et al.   MEDICINAL RESEARCH REVIEWS

Doxorubicin: The Good, the Bad and the Ugly Effect

(2009) Cristina Carvalho et al.   CURRENT MEDICINAL CHEMISTRY